Researchers have chosen an experimental drug by Eli Lilly & Co. for a large federally funded study aiming to prevent Alzheimer's disease in older people at high risk of developing it.The drug, called solanezumab (sol-ah-NAYZ-uh-mab), is designed to bind to and help clear the sticky deposits that clog patients' brains.Earlier ...